Share of Veru Inc. plunged 31.0% toward a 2 1/2-year low in premarket Friday, after the U.S. Food and Drug Administration turned down the biopharmaceutical...
Share of Veru Inc.
plunged 31.0% toward a 2 1/2-year low in premarket Friday, after the U.S. Food and Drug Administration turned down the biopharmaceutical company’s request for Emergency Use Authorization for sabizabulin, its treatment for hospitalized patients with COVID-19 who are at high risk for Acute Respiratory Distress Syndrome . The company said that although the FDA declined the EUA request, “the FDA remains committed to working with the company for the development of sabizabulin.
plunged 31.0% toward a 2 1/2-year low in premarket Friday, after the U.S. Food and Drug Administration turned down the biopharmaceutical company’s request for Emergency Use Authorization for sabizabulin, its treatment for hospitalized patients with COVID-19 who are at high risk for Acute Respiratory Distress Syndrome . The company said that although the FDA declined the EUA request, “the FDA remains committed to working with the company for the development of sabizabulin.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Reata’s stock jumps 175% in premarket trading after FDA approvalShares of Reata Pharmaceuticals Inc. soared about 175% in premarket trading on Wednesday, the day after the Food and Drug Administration approved Skyclarys,...
続きを読む »
Flu and COVID combo shots won't come in time for this year, FDA official saysThe FDA's goal is to roll out the combo option by the following flu season.
続きを読む »
FDA cracks down on ‘tranq’ imports due to new drug trendThe Food and Drug Administration is beefing up efforts to ensure that xylazine, an animal sedative known as “tranq,” is not diverted to the illicit drug supply.
続きを読む »
New FDA guidelines change how we look at 'healthy' foodsThe FDA is making changes to its definition of health foods. Nutritionist Dr. Daryl Gioffre says the previous standards were outdated. The FDA set its 'healthy' food guidelines back in 1994, so a change is well overdue.
続きを読む »
FDA Action Targets Xylazine Shipping Enforcement Because of Growing Health ConcernThe Food and Drug Administration announced an action that requires specific labeling, and allows divisions of the FDA to detain a Xylazine, a veterinary tranquilizer and painkiller used in large animal surgeries, when it is imported into the U.S.
続きを読む »
FDA to control import of 'zombie drug' xylazineThe Food and Drug Administration said it will restrict imports of an animal sedative infiltrating the opioid supply and making the effects of fentanyl even deadlier.
続きを読む »